17th International Process Development Conference to Feature Presentations on Safety, Process Development, Crystallization, PAT, Scale-Up and ... ( The 17th Int...)

HOME >> BIOLOGY >> TECHNOLOGY

17th International Process Development Conference to Feature Presentations on Safety, Process Development, Crystallization, PAT, Scale-Up and Production

Date:10/11/2009

The 17th International Process Development Conference will take place on May 16-19, 2010 in Baltimore, MD, USA. This innovative annual event offers a prestigious roster of industry professionals and pioneers who will share their knowledge and experience in process development, crystallization, safety, scale-up, production, and emerging technologies.

Columbia, MD (PRWEB) October 11, 2009 -- METTLER TOLEDO announces the 17th International Process Development Conference will take place May 16-19, 2010 in Baltimore, MD, USA. During the 17th International Process Development Conference, industry and academic speakers will give presentations on topics including process safety, process research & development, crystallization, Process Analytical Technology (PAT), scale-up and production.

The open forum format allows you the opportunity to learn and discuss the latest academia and industry developments. In addition to scientific presentations, there will be the opportunity to participate in product and application workshops.

During each International Process Development Conference, attendees have the opportunity to vote for the "Best Paper". The speaker with the most votes is announced during the Conference Awards dinner which takes place on the final evening of the Conference. The winner of the 2009 Best Paper Award was Adrian Daly from Pfizer, Ireland with his paper "

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2
Related biology technology :

1. Chicago-Based Celsis International Goes Private
2. Cryo-Cell Internationals Stem Cell Research and Development Helps the Fight Against Breast Cancer
3. Yongye International Announces 2010-2012 Strategic Plan
4. Max Neeman International to Open Phase I/IIa Unit
5. Sanford Rose Associates Joins the International Executive Search Federation
6. CBI Hosts Life Sciences Summit on International Trade Compliance
7. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) is Feasible in Patients Requiring Undeferrable Non-Cardiac Surgery, International Journal of Cardiology Publication Reports
8. SRA International Wins $16 Million Contract from Cancer Prevention and Research Institute of Texas
9. Vita-Tech International, Inc. Donates One Ton of Vitamins To Polio Treatment Centers in Guinea, West Africa
10. Sechrist Increases Focus on International Markets; Appoints William Preuit Senior Vice President
11. Beike Biotech Adds International Executives to Strengthen Current Technologies and Develop Future Pipeline

Post Your Comments:

(Date:12/16/2009)... 16 /PRNewswire/ -- Capitalizing ... sciences industry and an active venture capital market, ... State Teachers Retirement Fund, Indiana University, Purdue University, ... Foundation, and Credit Suisse today announced the establishment ... capital fund of funds. ,, Organized through BioCrossroads, ...

(Date:12/16/2009)... Sequenom, Inc. (Nasdaq: SQNM ), today announced ... David Pendarvis to its board of directors. ... F. Buechler, Ph.D., was president, chief scientific officer ... 1994, Dr. Buechler was Biosite,s director of chemistry. ... senior research scientist for the diagnostics research and ...

(Date:12/16/2009)... Eppendorf has initiated an,import ban for Nanosphere, ... of European patent EP 1 179 180 ... quantification of a target compound". The import,ban ... respective products into any country of,the European ... any,violating products. , ...

(Date:12/15/2009)... 15 Epeius Biotechnologies Corporation, an emerging ... gained international validation of the cutting-edge science behind ... scientists around the world rediscovered the Cyclin ... of cancer pathogenesis and disease progression, and thus ... at the NIH National Cancer Institute investigating the ...

Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2 Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3 Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4 Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5 Sequenom Appoints Two New Board Members 2 Sequenom Appoints Two New Board Members 3 Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2 Scientists Rediscover Gene Target for Cancer Therapy 2 Scientists Rediscover Gene Target for Cancer Therapy 3

[0] Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth [0] Sequenom Appoints Two New Board Members [0] Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union [0] Scientists Rediscover Gene Target for Cancer Therapy

... 1,200 new, jobs within 36 months of initiating operations in its second ... ... St. Jude,Medical, Inc. (NYSE: STJ ) today announced plans to expand ... Industrial Park, which will allow the company to increase its,Puerto Rico operations by ...

... Coulter,Inc. (NYSE: BEC ), a leading developer, ... innovate complex biomedical testing,announced today that Charles Slacik, ... will present at the 2007 UBS Global,Life Sciences ... p.m.,(EDT). (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) The ...

... BIRMINGHAM, Ala., Sept. 19 BioCryst,Pharmaceuticals, Inc. ... findings,from a Phase II study with intramuscular ... for the treatment of seasonal and,life-threatening influenza. ... The study was a randomized, double-blind, placebo-controlled ...

Other Biology Technology:St. Jude Medical to Expand Puerto Rico Operations 2 Beckman Coulter to Present at the UBS Global Life Sciences Conference 2 BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza 2 BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza 3 BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza 4 BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza 5 BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza 6 BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza 7

St. Jude Medical to Expand Puerto Rico Operations Beckman Coulter to Present at the UBS Global Life Sciences Conference BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza

(Date:12/16/2009)... iQor, a global provider of business process ... InfoWorld 100 Awards Top 100 IT project of ... the first submission for iQor. ,, "We are honored ... said Vikas Kapoor, president and CEO of iQor. "TeQ21 ... us to work faster, smarter and with the added ...

(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin ... safety and finger-based biometric identification solutions, announced ... a Special Shareholder Meeting held today approved ... Division to Interact911 Mobile Systems Inc. Of ... favor and 1.2% were opposed. ,, (Logo: ...

(Date:12/16/2009)... Va., Dec. 9 CSC (NYSE: ... the American Association for Laboratory Accreditation awarded ... (ISO/IEC) 17025:2005 accreditation to the company,s Test ... Identity Labs located in Fairmont, W.Va. The ... laboratory in the world to achieve this ...

Breaking Biology News(10 mins):iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2 BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2 BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3 CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 1 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 2 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 3 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 4 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 5 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 6 AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia 13582 7 US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 1 US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 2 US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 3 US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 4 US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 5 US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 6 US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 7 A crystal ball for brain cancer 3F 54598 1 A crystal ball for brain cancer 3F 54598 2 A crystal ball for brain cancer 3F 54598 3

[0] iQor Named to InfoWorld 100 List of Top IT Projects of 2009 [0] BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division [0] CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation

... AWRE ) today announced that it has amended and ... of comments and a request from the Securities and Exchange ... range of the tender offer to between $2.20 and $2.60 ... share. Aware has also extended the expiration date for the ...

... Improve Application Processing for Passports and Identity CardsFALLS CHURCH, ... ) today announced that the UK Identity and Passport ... responsible for issuing UK passports and ID cards, has ... services contract to upgrade the IPS application and enrollment ...

... 6, 2009 -- Which is a better strategy, ... conventional cropping more profitable than organic farming? Is ... the University of Wisconsin,s College of Agriculture and ... established the Wisconsin Integrated Cropping Systems Trial (WICST) ...

Other Biology News:Aware, Inc. Amends and Extends Dutch Auction Tender Offer 2 Aware, Inc. Amends and Extends Dutch Auction Tender Offer 3 Aware, Inc. Amends and Extends Dutch Auction Tender Offer 4 CSC Awarded $570 Million IT Services Contract by UK Identity and Passport Service 2

Aware, Inc. Amends and Extends Dutch Auction Tender Offer CSC Awarded $570 Million IT Services Contract by UK Identity and Passport Service Can organic cropping systems be as profitable as conventional systems?

dithiothreitol (DTT) Reactive Dyes and Chemicals Thiol-Reactive Dyes, Haptens and Quenchers Reducing Agents...

Recombinant Equine IL-4, CF...

VACUGENE PUMP 110V, 1 EA. Category: Nucleid Acid Detection Systems....

...

Biology Products:

dithiothreitol (DTT) from Molecular Probes (Invitrogen)Equine IL-4, Unconjugated from R&D Systems VACUGENE PUMP 110V from GE Healthcare, formerly Amersham Biosciences Cryopreservation Service from AbD Serotec

17th International Process Development Conference to Feature Presentations on Safety, Process Development, Crystallization, PAT, Scale-Up and ...( The 17th Int...)